TrialPediatric dermatology

Low Infection Rates With Long-Term Dupilumab Treatment in Patients Aged 6 Months to 5 Years: An Open-Label Extension Study.

Amy S Paller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.